{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:03:09Z","timestamp":1774436589302,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-025-03353-6","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:58:57Z","timestamp":1739998737000},"page":"1001-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Future challenges of imaging in cardiac amyloidosis"],"prefix":"10.1007","volume":"41","author":[{"given":"Laurenz","family":"Hauptmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Autherith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kammerlander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Duca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"4","key":"3353_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","volume":"16","author":"A Ioannou","year":"2023","unstructured":"Ioannou A, Patel RK, Razvi Y, Porcari A, Knight D, Martinez-Naharro A et al (2023) Multi-imaging characterization of Cardiac phenotype in different types of amyloidosis. JACC Cardiovasc Imaging 16(4):464\u2013477","journal-title":"JACC Cardiovasc Imaging"},{"issue":"1","key":"3353_CR2","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","volume":"14","author":"D Genovesi","year":"2021","unstructured":"Genovesi D, Vergaro G, Giorgetti A, Marzullo P, Scipioni M, Santarelli MF et al (2021) [18F]-Florbetaben PET\/CT for Differential diagnosis among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and mimicking conditions. JACC Cardiovasc Imaging 14(1):246\u2013255","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"3353_CR3","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jcmg.2022.03.005","volume":"15","author":"C Nitsche","year":"2022","unstructured":"Nitsche C, Mascherbauer K, Wollenweber T, Koschutnik M, Don\u00e0 C, Dannenberg V et al (2022) The complexity of subtle Cardiac Tracer Uptake on Bone Scintigraphy. JACC Cardiovasc Imaging 15(8):1516\u20131518","journal-title":"JACC Cardiovasc Imaging"},{"key":"3353_CR4","doi-asserted-by":"crossref","unstructured":"Nitsche C, Mascherbauer K, Calabretta R, Koschutnik M, Dona C, Dannenberg V et al (2022) Prevalence and outcomes of cardiac amyloidosis in all-comer referrals for bone scintigraphy. J Nucl Med","DOI":"10.1093\/eurheartj\/ehab724.0280"},{"key":"3353_CR5","doi-asserted-by":"crossref","unstructured":"Porcari A, Razvi Y, Cappelli F, Nitsche C, Serenelli M, Longhi S et al (2025) Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration. JAMA Cardiol","DOI":"10.1001\/jamacardio.2024.5221"},{"issue":"2","key":"3353_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","volume":"77","author":"C Nitsche","year":"2021","unstructured":"Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C et al (2021) Prevalence and outcomes of concomitant aortic stenosis and Cardiac Amyloidosis. J Am Coll Cardiol 77(2):128\u2013139","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"3353_CR7","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/ejhf.1756","volume":"22","author":"C Nitsche","year":"2020","unstructured":"Nitsche C, Aschauer S, Kammerlander AA, Schneider M, Poschner T, Duca F et al (2020) Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome. Eur J Heart Fail 22(10):1852\u20131862","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"3353_CR8","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jcin.2022.06.009","volume":"15","author":"C Don\u00e0","year":"2022","unstructured":"Don\u00e0 C, Nitsche C, Koschutnik M, Heitzinger G, Mascherbauer K, Kammerlander AA et al (2022) Unveiling Cardiac Amyloidosis, its characteristics, and outcomes among patients with MR undergoing transcatheter edge-to-edge MV Repair. JACC Cardiovasc Interv 15(17):1748\u20131758","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"3353_CR9","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/S2589-7500(23)00265-0","volume":"6","author":"CP Spielvogel","year":"2024","unstructured":"Spielvogel CP, Haberl D, Mascherbauer K, Ning J, Kluge K, Traub-Weidinger T et al (2024) Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation study. Lancet Digit Health 6(4):e251\u2013e260","journal-title":"Lancet Digit Health"},{"key":"3353_CR10","doi-asserted-by":"crossref","unstructured":"Duca F, Rettl R, Kronberger C, Binder C, Mann C, Dusik F et al (2023) Myocardial structural and functional changes in cardiac amyloidosis - insights from a prospective observational patient registry. Eur Heart J Cardiovasc Imaging","DOI":"10.1093\/ehjci\/jead188"},{"key":"3353_CR11","unstructured":"Rettl R, Calabretta R, Duca F, Binder C, Kronberger C, Willixhofer R et al Reduction in (99m)Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy. Amyloid 2023:1\u201310"},{"issue":"1","key":"3353_CR12","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/S2589-7500(20)30267-3","volume":"3","author":"JB Augusto","year":"2021","unstructured":"Augusto JB, Davies RH, Bhuva AN, Knott KD, Seraphim A, Alfarih M et al (2021) Diagnosis and risk stratification in hypertrophic cardiomyopathy using machine learning wall thickness measurement: a comparison with human test-retest performance. Lancet Digit Health 3(1):e20\u2013e28","journal-title":"Lancet Digit Health"},{"issue":"1","key":"3353_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jacc.2024.05.003","volume":"84","author":"R Khera","year":"2024","unstructured":"Khera R, Oikonomou EK, Nadkarni GN, Morley JR, Wiens J, Butte AJ et al (2024) Transforming Cardiovascular Care with Artificial Intelligence: from Discovery to Practice: JACC State-of-the-art review. J Am Coll Cardiol 84(1):97\u2013114","journal-title":"J Am Coll Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-025-03353-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03353-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:31:52Z","timestamp":1747153912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-025-03353-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":13,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["3353"],"URL":"https:\/\/doi.org\/10.1007\/s10554-025-03353-6","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"C.N. reports speaker\/consulting honoraria from Pfizer, Bayer, Prothena, and B\u00f6hringer Ingelheim and research contracts with Pfizer and AstraZeneca. The remaining authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}